VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2024. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $5,776,000 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,500,000 | $129,120,000 | 26.54% |
| Brave Warrior Advisors | 6,657,451 | $573,073,000 | 26.54% |
| Scotia Institutional Investments US, LP | 126,608 | $10,916,000 | 20.81% |
| Ruane, Cunniff & Goldfarb | 34,738,116 | $2,990,257,000 | 19.25% |
| Ratan Capital Management LP | 437,383 | $37,650,000 | 18.73% |
| ValueAct Holdings | 18,923,877 | $1,628,967,000 | 16.73% |
| FARLEY CAPITAL L.P. | 246,856 | $21,249,000 | 16.14% |
| Brahman Capital Corp. | 3,850,317 | $331,435,000 | 13.05% |
| Hound Partners | 2,307,000 | $198,587,000 | 10.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 795,743 | $68,498,000 | 10.28% |